After 6 months of ARV treatment, the rate of undetectable HBV DNA was more 11.5 times than the baseline; in HBV DNA positive group, 91.8% of the patients had complete viral response and 8.2% patients had partial viral response, no patients had HBV DNA increased; in HBV DNA negative group, 7% patients had HBV DNA relapse.